Intrexon, a US-based synthetic biology company, has closed its series E round at $100m, bringing the company’s total capital raised to more than $259m. New investors took the majority of the round while existing investors, including billionaire Randal Kirk, Intrexon’s executive chairman, through his Third Security venture investment unit, and Sandbox Industries, a venture capital…
- News & Analysis
- Global Corporate Venturing
- Global University Venturing
- Latest News
- Deal Data
- Community & Events
Intrexon closes at $100m
Aug 5, 2012 • Global Corporate Venturing
LEADERSHIP SOCIETYInforming, connecting, and transforming the global corporate venture capital ecosystem.
The Global Corporate Venturing (GCV) Leadership Society’s mission is to help bridge the different strengths and ambitions of investors across industry sectors, geography, structure, and their returns.
Featured ContentFUNDING ROUND DATA Which corporates are backing which startups? Search our corporate deal database.
FUNDING ROUND DATA
Which corporates are backing which startups? Search our corporate deal database.PEOPLE These are the 100 people shaping the future of corporate investment
These are the 100 people shaping the future of corporate investmentEventsWebinar: Functional Foods - Investors are hungry for moreEventsCorporate Venture in Brasil 2023 – International Delegation to BrazilEventsGCV Asia 2023 - International Delegation to Japan & South KoreaTop News
GCV provides the global corporate venturing community and their ecosystem partners with the information, insights and access needed to drive impactful open innovation. Across our three services - News & Analysis, Community & Events, and the GCV Institute - we create a network-rich environment for global innovation and capital to meet and thrive. At the heart of our community sits the GCV Leadership Society, providing privileged access to all our services and resources.test reg